McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., & Schnell, M. J. (2003). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. American Society for Microbiology.
Citación estilo ChicagoMcGettigan, James P., Roger J. Pomerantz, Catherine A. Siler, Philip M. McKenna, Heather D. Foley, B. Dietzschold, y Matthias J. Schnell. Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. American Society for Microbiology, 2003.
Cita MLAMcGettigan, James P., et al. Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. American Society for Microbiology, 2003.